Weill Cornell is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Weill Cornell has participated in 25 clinical trials with 15 currently active.
Therapeutic areas: Autoimmune Disorders, Unruptured Wide-neck Aneurysms, Cancer.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Stryker Neurovascular, Jounce Therapeutics, Inc..
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell has 25 clinical trials on record, with 15 currently active. Their work covers Autoimmune Disorders, Unruptured Wide-neck Aneurysms, Cancer.
Yes — Weill Cornell holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.